| Pharmaceuticals Industry | Healthcare Sector | - CEO | KRX SM Exchange | - ISIN |
| South Korea Country | - Employees | - Last Dividend | 29 Dec 2008 Last Split | - IPO Date |
Sam-A Pharmaceutical Co., Ltd. stands as a distinguished entity in the pharmaceutical sector, acclaimed for its comprehensive involvement in the formulation, production, and distribution of a broad range of medicinal offerings. This company places a strong emphasis on generating both prescription and over-the-counter (OTC) medications alongside medical supplies, catering to diverse therapeutic fields. With a product range aimed at tackling myriad health conditions, Sam-A Pharmaceutical is pivotal in enhancing patient welfare and bolstering public health standards.
Rooted in South Korea, the enterprise capitalizes on state-of-the-art research and development facilities to forge and present efficacious healthcare solutions. It caters to the needs of both local and global markets, underscoring its dedication towards amplifying its international presence and facilitating wider access to premier healthcare commodities.
In the healthcare realm, Sam-A Pharmaceutical is instrumental in advancing the management of chronic diseases and the field of preventive medicine. Through persistent investment in avant-garde technology and strategic alliances with international research institutions, the company cements its role as a vital force in propelling the pharmaceutical industry's evolution and stability. Its prominence in the market accentuates the essential role of pharmaceuticals in enhancing and maintaining optimal health outcomes across the globe.
Sam-A Pharmaceutical’s vast product suite is tailored to meet the healthcare requirements across various domains, including: